Profile
Sarah Singleton currently works at ImmunityBio, Inc., as Chief Communications Officer from 2020.
Ms. Singleton also formerly worked at NantKwest, Inc., as Head-Global Communications & Investor Relations, Sunverge Energy, Inc., as Senior Vice President-Marketing, and Fleishman-Hillard, Inc., as Senior Vice President & Partner.
Ms. Singleton received her undergraduate degree from E.W.
Scripps School of Journalism.
Sarah Singleton active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNITYBIO, INC. | Public Communications Contact | 01/03/2020 |
Former positions of Sarah Singleton
| Companies | Position | End |
|---|---|---|
| IMMUNITYBIO, INC. | Investor Relations Contact | 01/01/2019 |
Fleishman-Hillard, Inc.
Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Corporate Officer/Principal | - |
Sunverge Energy, Inc.
Sunverge Energy, Inc. Packaged SoftwareTechnology Services Develops cloud-based energy management platform | Sales & Marketing | - |
Training of Sarah Singleton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
NantKwest, Inc.
NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
Sunverge Energy, Inc.
Sunverge Energy, Inc. Packaged SoftwareTechnology Services Develops cloud-based energy management platform | Technology Services |
Fleishman-Hillard, Inc.
Fleishman-Hillard, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public relations services | Commercial Services |
E.W. Scripps School of Journalism
E.W. Scripps School of Journalism Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ImmunityBio, Inc.
ImmunityBio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for immunogenic mechanisms for defeating cancer and infectious disease | Health Technology |
- Stock Market
- Insiders
- Sarah Singleton
















